SCHEMBL5107498

SCHEMBL5107498

CS(=O)(=O)c1ccc(C(=O)COc2ccc(F)cc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.58
LMNA P02545 1/20 0.58
CASP3 P42574 1/20 0.58
SENP7 Q9BQF6 1/20 0.58
SENP6 Q9GZR1 1/20 0.58
L3MBTL1 Q9Y468 1/20 0.58
GAA P10253 2/20 0.49
ALDH1A1 P00352 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2D6 P10635 1/20 0.49
PKM P14618 1/20 0.49
ALOX15 P16050 1/20 0.49
TSHR P16473 1/20 0.49
CYP2C19 P33261 1/20 0.49
MAPT P10636 3/20 0.49
PTGS2 P35354 2/20 0.49
TP53 P04637 1/20 0.48
NPSR1 Q6W5P4 1/20 0.48
HSD17B10 Q99714 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6327817 0.86 LMNA (0.73) MAPK1LMNACASP3SENP7SENP6
SCHEMBL5097617 0.85 MAPT (0.52) LMNAGAAALDH1A1MAPTAKR1C3
SCHEMBL27608859 0.85 MAPT (0.55) MAPK1LMNAL3MBTL1GAAALDH1A1
SCHEMBL5094149 0.85 MAPT (0.55) MAPK1LMNAL3MBTL1GAAALDH1A1
SCHEMBL11488970 0.81 MAPT (0.64) MAPK1LMNACASP3SENP7SENP6
SCHEMBL6318784 0.81 MAPT (0.64) MAPK1LMNACASP3SENP7SENP6
SCHEMBL11847871 0.81 LMNA (0.64) MAPK1LMNACASP3SENP7SENP6
SCHEMBL5107072 0.81 SLC6A4 (0.44) PTGS2
SCHEMBL5107058 0.80 MRGPRX4 (0.45) LMNAMAPTPTGS2TP53NPSR1
SCHEMBL6204121 0.78 LMNA (0.64) MAPK1LMNACASP3SENP7SENP6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7354936-B2 2-phenylpyran-4-one derivatives ALMIRALL AG (CH) 2008-04-08 US disclosed
EP-1263751-B1 2-PHENYLPYRAN-4-ONE DERIVATIVES ALMIRALL PRODESFARMA AG (CH) 2004-06-16 EP disclosed
US-20030232880-A1 2-Phenylpyran-4-one derivatives LABORATORIOS ALMIRALL, S.A. (ES) 2003-12-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030232880-A1 2-Phenylpyran-4-one derivatives CYP3A4, UGT1A4, CYP4B1 MAPK1 2451/4885LMNA 3689/4885CASP3 2831/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.